Integrity is the foundation of good science. It is needed to ensure the public’s trust and the lack of it becomes a danger to the public’s welfare. This is especially true in medical science, where a conflict of interest may lead to approval of a drug or technique that is potentially harmful to the patient. And whether a conflict of interest is real or perceived, it has serious repercussions to advancing medical science. This is why an article published yesterday in the NYT and elsewhere that showed that a group investigating lung cancer screening technologies was funded by a tobacco…

Read More

It is with great sadness to share that John Slatin passed away on Monday, March 24 after a long battle with leukemia. John was truly a survivor who embodied LIVESTRONG in each day of his life.

John lost his eyesight and became involved in accessibility issues long before the Internet looked anything like it is today. He championed web accessibility, where I first saw his name on the book called “Maximum Accessibility: Making Your Web Site More Usable for Everyone.”

He is the founding Director of the Institute for Technology and Learning at the University of Texas at Austin. He became an international…

Read More

If you want to see the confluence of passion, hope and inspiration watch Randy Pausch’s testimony from Congress.

Doug

Read More

I wanted to take the time to pay tribute to the life and achievements of a leader in the cancer survivorship community √¢‚Ǩ‚Äú Mary Lovato. Mary, the winner of the 2002 Carpe Diem Award from the Lance Armstrong Foundation, has passed away. She exemplified what it means to LIVESTRONG and as a result, many Native American communities throughout our nation now talk about cancer in a more open and supportive way. Mary continued to educate her people and provide guidance to other organizations attempting to address health disparities in Native American communities until the very end. As recently as last year,…

Read More

Hey there! Here’s an amazing story in today’s NY Times that I wanted to share with everyone.

Second Opinion
The New York Times
March 18, 2008

A Daring Treatment, a Little Girl’s Survival
By DENISE GRADY

In the pages of a medical journal, Melanie Joy McDaniel is a study subject, listed by her patient number and tumor type. In real life she’s a little girl whose story is a reminder that medical research can change lives and that the pioneers include patients, some of whom are babies.

Melanie was 9 months old when her parents faced an agonizing decision. She had already had two operations…

Read More